Literature DB >> 17170444

Epidemic dynamics of two coexisting hepatitis C virus subtypes.

Nuria Jiménez-Hernández1, Manuela Torres-Puente, Maria Alma Bracho, Inmaculada García-Robles, Enrique Ortega, Juan del Olmo, Fernando Carnicer, Fernando González-Candelas, Andrés Moya.   

Abstract

Hepatitis C virus (HCV) infection affects about 3% of the human population. Phylogenetic analyses have grouped its variants into six major genotypes, which have a star-like distribution and several minor subtypes. The most abundant genotype in Europe is the so-called genotype 1, with two prevalent subtypes, 1a and 1b. In order to explain the higher prevalence of subtype 1b over 1a, a large-scale sequence analysis (100 virus clones) has been carried out over 25 patients of both subtypes in two regions of the HCV genome: one comprising hypervariable region 1 and another including the interferon sensitivity-determining region. Neither polymorphism analysis nor molecular variance analysis (attending to intra- and intersubtype differences, age, sex and previous history of antiviral treatment) was able to show any particular difference between subtypes that might account for their different prevalence. Only the demographic history of the populations carrying both subtypes and analysis of molecular variance (AMOVA) for risk practice suggested that the route of transmission may be the most important factor to explain the observed difference.

Entities:  

Mesh:

Year:  2007        PMID: 17170444     DOI: 10.1099/vir.0.82277-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  10 in total

1.  Cellular immune response to infection by different genotypes of hepatitis C virus.

Authors:  Mohamed El-Shahat Ebeid; Kadry Abdel-Kader El-Bakry
Journal:  Indian J Clin Biochem       Date:  2009-09-16

2.  Viral phylodynamics and the search for an 'effective number of infections'.

Authors:  Simon D W Frost; Erik M Volz
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2010-06-27       Impact factor: 6.237

3.  Baseline prediction of combination therapy outcome in hepatitis C virus 1b infected patients by discriminant analysis using viral and host factors.

Authors:  Verónica Saludes; Maria Alma Bracho; Oliver Valero; Mercè Ardèvol; Ramón Planas; Fernando González-Candelas; Vicente Ausina; Elisa Martró
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

4.  Composition of inflammatory infiltrate and its correlation with HBV/HCV antigen expression.

Authors:  Bozena Walewska-Zielecka; Kazimierz Madalinski; Joanna Jablonska; Paulina Godzik; Joanna Cielecka-Kuszyk; Bogumila Litwinska
Journal:  World J Gastroenterol       Date:  2008-07-07       Impact factor: 5.742

Review 5.  Recombination in hepatitis C virus.

Authors:  Fernando González-Candelas; F Xavier López-Labrador; María Alma Bracho
Journal:  Viruses       Date:  2011-10-24       Impact factor: 5.048

6.  Evidence of recombination in intrapatient populations of hepatitis C virus.

Authors:  Vicente Sentandreu; Nuria Jiménez-Hernández; Manuela Torres-Puente; María Alma Bracho; Ana Valero; María José Gosalbes; Enrique Ortega; Andrés Moya; Fernando González-Candelas
Journal:  PLoS One       Date:  2008-09-18       Impact factor: 3.240

7.  A novel approach to identify candidate prognostic factors for hepatitis C treatment response integrating clinical and viral genetic data.

Authors:  Alicia Amadoz; Fernando González-Candelas
Journal:  Evol Bioinform Online       Date:  2015-02-23       Impact factor: 1.625

8.  Relevance of baseline viral genetic heterogeneity and host factors for treatment outcome prediction in hepatitis C virus 1b-infected patients.

Authors:  Verónica Saludes; Elisabet Bascuñana; Elena Jordana-Lluch; Sònia Casanovas; Mercè Ardèvol; Esther Soler; Ramón Planas; Vicente Ausina; Elisa Martró
Journal:  PLoS One       Date:  2013-08-28       Impact factor: 3.240

9.  Complete genome of a European hepatitis C virus subtype 1g isolate: phylogenetic and genetic analyses.

Authors:  Maria A Bracho; Verónica Saludes; Elisa Martró; Ana Bargalló; Fernando González-Candelas; Vicent Ausina
Journal:  Virol J       Date:  2008-06-05       Impact factor: 4.099

10.  Genetic variability of hepatitis C virus before and after combined therapy of interferon plus ribavirin.

Authors:  José Manuel Cuevas; Manuela Torres-Puente; Nuria Jiménez-Hernández; María Alma Bracho; Inmaculada García-Robles; Boris Wrobel; Fernando Carnicer; Juan del Olmo; Enrique Ortega; Andrés Moya; Fernando González-Candelas
Journal:  PLoS One       Date:  2008-08-26       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.